Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devon S Conway

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 17, 2017
Sphingosine 1-Phosphate Receptor Modulators for the Treatment of Multiple SclerosisBurhan Z Chaudhry, Jeffrey A Cohen, Devon S Conway
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 28, 2016
Influence of hypertension, diabetes, hyperlipidemia, and obstructive lung disease on multiple sclerosis disease courseDevon S Conway, Nicolas R Thompson, Jeffrey A Cohen
Multiple Sclerosis and Related Disorders|May 31, 2021
Characterizing relapsing remitting multiple sclerosis patients burdened with hypertension, hyperlipidemia, and asthmaAlena Sorensen, Devon S Conway, Farren B S Briggs
Multiple Sclerosis and Related Disorders|September 21, 2016
Lack of magnetic resonance imaging lesion activity as a treatment target in multiple sclerosis: An evaluation using electronically collected outcomesDevon S Conway, Nicolas R Thompson, Jeffrey A Cohen
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 29, 2017
Multiple Sclerosis: Unprecedented Progress But Significant Challenges AheadDevon S Conway, Le H Hua, Jeffrey A Cohen
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 12, 2022
The relationship between cognition, education, and employment in multiple sclerosis patientsDevon S Conway, Robert A Bermel, Sarah M Planchon
Multiple Sclerosis and Related Disorders|February 4, 2019
Prognostic factors of disability in relapsing remitting multiple sclerosisFarren B S Briggs, Nicolas R Thompson, Devon S Conway
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 18, 2021
Age of hypertension onset in multiple sclerosis patientsFarren Bs Briggs, Diane Krill, Eddie Hill, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|July 4, 2020
Is Obesity Related to Processing Speed Impairment in Patients with Multiple Sclerosis: Results of a Large-Scale, Multicenter StudyRachel Galioto, Devon S Conway, Sarah M Planchon, et al.
Multiple Sclerosis and Related Disorders|January 1, 2026
Self-harm-related mortality among U.S. decedents with multiple sclerosis: A nationwide analysis (1999-2020)Moaz Elsayed Abouelmagd, Belal Mohamed Hamed, Mostafa Meshref, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 17, 2017
Sphingosine 1-Phosphate Receptor Modulators for the Treatment of Multiple SclerosisBurhan Z Chaudhry, Jeffrey A Cohen, Devon S Conway
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 28, 2016
Influence of hypertension, diabetes, hyperlipidemia, and obstructive lung disease on multiple sclerosis disease courseDevon S Conway, Nicolas R Thompson, Jeffrey A Cohen
Multiple Sclerosis and Related Disorders|May 31, 2021
Characterizing relapsing remitting multiple sclerosis patients burdened with hypertension, hyperlipidemia, and asthmaAlena Sorensen, Devon S Conway, Farren B S Briggs
Multiple Sclerosis and Related Disorders|September 21, 2016
Lack of magnetic resonance imaging lesion activity as a treatment target in multiple sclerosis: An evaluation using electronically collected outcomesDevon S Conway, Nicolas R Thompson, Jeffrey A Cohen
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 29, 2017
Multiple Sclerosis: Unprecedented Progress But Significant Challenges AheadDevon S Conway, Le H Hua, Jeffrey A Cohen
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 12, 2022
The relationship between cognition, education, and employment in multiple sclerosis patientsDevon S Conway, Robert A Bermel, Sarah M Planchon
Multiple Sclerosis and Related Disorders|February 4, 2019
Prognostic factors of disability in relapsing remitting multiple sclerosisFarren B S Briggs, Nicolas R Thompson, Devon S Conway
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 18, 2021
Age of hypertension onset in multiple sclerosis patientsFarren Bs Briggs, Diane Krill, Eddie Hill, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|July 4, 2020
Is Obesity Related to Processing Speed Impairment in Patients with Multiple Sclerosis: Results of a Large-Scale, Multicenter StudyRachel Galioto, Devon S Conway, Sarah M Planchon, et al.
Multiple Sclerosis and Related Disorders|January 1, 2026
Self-harm-related mortality among U.S. decedents with multiple sclerosis: A nationwide analysis (1999-2020)Moaz Elsayed Abouelmagd, Belal Mohamed Hamed, Mostafa Meshref, et al.
Pageof 6